Eckert & Ziegler to expand in Austria

27-Jun-2013 - Austria

Eckert & Ziegler will purchase all shares in BSM Diagnostica Gesellschaft m.b.H., based in Vienna, Austria, effective July 1, 2013. BSM is one of the leading providers in Austria of FDG (18F fluordeoxyglucose), a radiodiagnostic used in positron emission tomography (PET) scanning. The company manufactures FDG in its own cyclotron at Seibersdorf Laboratories.

Dr. André Heß, Eckert & Ziegler’s Executive Board member responsible for the Radiopharma segment, explains: “By purchasing BSM, we now have the necessary infrastructure at our fingertips to produce radiodiagnostics in Austria and supply them quickly and easily to nuclear clinics and other institutions. However, we also plan to expand our geographic coverage to include existing and new diagnostic centers in Central and Eastern Europe. We believe that radiodiagnostics will play an essential role in personalized medicine. Performing a diagnostic scan prior to treatment will make it possible to use therapeutics in a more targeted manner.”

https://www.bionity.com/en/news/143761/eckert-ziegler-to-expand-in-austria.html